title: Free testosterone drives cancer aggressiveness: evidence from US population studies.
abstract: Cancer incidence and mortality are higher in males than in females, suggesting that some gender-related factors are behind such a difference. To analyze this phenomenon the most recent Surveillance, Epidemiology and End Results (SEER) database served to access cancer survival data for the US population. Patients with gender-specific cancer and with limited information were excluded and this fact limited the sample size to 1,194,490 patients. NHANES III provided the distribution of physiologic variables in US population (n = 29,314). Cox model and Kaplan-Meier method were used to test the impact of gender on survival across age, and to calculate the gender-specific hazard ratio of dying from cancer five years following diagnosis. The distribution of the hazard ratio across age was then compared with the distribution of 65 physiological variables assessed in NHANES III. Spearman and Kolmogorov-Smirnov test assessed the homology. Cancer survival was lower in males than in females in the age range 17 to 61 years. The risk of death from cancer in males was about 30% higher than that of females of the same age. This effect was present only in sarcomas and epithelial solid tumors with distant disease and the effect was more prominent in African-Americans than Caucasians. When compared to the variables assessed in the NHANES III study, the hazard ratio almost exactly matched the distribution of free testosterone in males; none of the other analyzed variables exhibited a similar homology. Our findings suggest that male sex hormones give rise to cancer aggressiveness in patients younger than 61 years.
authors: Reproductive Tumor Biology Research, Department of Obstetrics and Gynecology, Danbury Hospital Research Institute, Danbury, Connecticut, United States of America.
authors: Shohreh
authors: S
authors: Shahabi
authors: Shiquan
authors: S
authors: He
authors: Michael
authors: M
authors: Kopf
authors: Marisa
authors: M
authors: Mariani
authors: Joann
authors: J
authors: Petrini
authors: Giovanni
authors: G
authors: Scambia
authors: Cristiano
authors: C
authors: Ferlini
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D018450:Disease Progression; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009369:Neoplasms / Q000453:epidemiology / Q000378:metabolism* / Q000473:pathology*; D011159:Population Surveillance; D018426:SEER Program; D012737:Sex Factors; D013739:Testosterone / Q000378:metabolism*; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D013739:Testosterone
references: J Clin Endocrinol Metab. 2013 Jan;98(1):E87-91
references: 23162102
references: J Bone Miner Res. 2001 May;16(5):911-7
references: 11341336
references: Gene. 2008 Feb 15;409(1-2):100-8
references: 18178340
references: J Clin Endocrinol Metab. 2007 Aug;92(8):3060-7
references: 17550960
references: J Clin Endocrinol Metab. 2006 Nov;91(11):4326-34
references: 16912139
references: Cancer Res. 2010 Jul 15;70(14):5891-900
references: 20587520
references: Hum Reprod. 1996 Jul;11(7):1484-6
references: 8671489
references: Gend Med. 2006 Jun;3(2):79-92
references: 16860268
references: JAMA. 1993 Jun 16;269(23):3009-14
references: 8501843
references: Clin Cancer Res. 2012 May 15;18(10):2964-75
references: 22438565
references: Semin Surg Oncol. 1992 Mar-Apr;8(2):57-61
references: 1615264
references: Am J Clin Nutr. 1997 Dec;66(6):1323-31
references: 9394682
references: Clin Cancer Res. 2011 Sep 15;17(18):5913-25
references: 21807635
references: J Clin Endocrinol Metab. 2007 Jul;92(7):2519-25
references: 17456570
references: Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1174-82
references: 19293308
references: Pediatrics. 2003 Jan;111(1):110-3
references: 12509562
references: JAMA. 1990 Apr 25;263(16):2189-93
references: 2319685
references: Eur J Cancer. 2009 Apr;45(6):1017-27
references: 19109009
references: Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1629-37
references: 21750167